Dendreon files for bankruptcy as cancer vaccine disappoints

November 10, 2014 5:48 PM

2 0

(Reuters) - Dendreon Corp filed for Chapter 11 bankruptcy protection after sales of the world's first cancer vaccine fell short of expectations and left the company deep in debt.

More than two-thirds of the company's market value was wiped out in early trading on Monday.

Also read: Celgene quarterly revenue rises 28 percent as Revlimid shines

Read more

To category page